Nuwellis Inc. announced it has received a notice of allowance from the United States Patent and Trademark Office for a new patent covering advanced safety mechanisms for blood return line clamps used in extracorporeal blood filtration systems. The patent applies to the Vivian™ Pediatric Continuous Renal Replacement Therapy (CRRT) System, which is currently in development. The technology aims to enhance safety by dynamically adjusting clamping force, automatically reconditioning tubing under thermal conditions, and adding thermal insulation for improved material stability. This addition strengthens the company's intellectual property portfolio and supports ongoing innovation in pediatric fluid management.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.